- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
GlaxoSmithKline Pharmaceuticals has announced a leadership change with Ms. Sukanya Choudhury, Executive Vice President - Regulatory Affairs, taking a 16-month secondment as Regulatory Head for Growth Emerging Markets. She will step away from senior management during this period. This shift highlights a strategic move in regulatory leadership, which could affect the company’s growth efforts and regulatory strategy in emerging markets, an important area for expanding the business.
All announcements from GlaxoSmithKline Pharmaceuticals Limited